Quanterix (NASDAQ:QTRX) Issues Quarterly Earnings Results, Misses Estimates By $0.03 EPS

Quanterix (NASDAQ:QTRX) released its quarterly earnings data on Monday. The company reported ($0.30) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by ($0.03), Zacks reports. The business had revenue of $35.16 million during the quarter, compared to the consensus estimate of $34.93 million. Quanterix had a negative net margin of 30.12% and a negative return on equity of 11.74%. Quanterix updated its FY 2025 guidance to EPS.

Quanterix Price Performance

NASDAQ:QTRX opened at $7.15 on Wednesday. The firm has a market capitalization of $275.45 million, a price-to-earnings ratio of -6.75 and a beta of 1.34. Quanterix has a one year low of $6.30 and a one year high of $27.37. The business has a fifty day moving average price of $8.41 and a 200-day moving average price of $10.93.

Analyst Ratings Changes

Separately, Canaccord Genuity Group decreased their target price on shares of Quanterix from $20.00 to $15.00 and set a “buy” rating for the company in a research note on Tuesday.

About Quanterix

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.